Sample Report | Order Information
| Period ending date | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|---|---|
| Number of months in period | 12 | 12 | 12 | 12 | 12 |
| Cost report status | As Submitted | As Submitted | Settled With Audit | Reopened | Settled Without Audit |
| EBITDAR - Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent | $174,872,173 | $174,883,830 | $412,265,192 | $179,243,108 | $241,949,739 |
| Definition: net income + interest + depreciation and amortization + lease cost | |||||
| net income (before taxes) | $79,825,219 | $80,098,761 | $325,067,409 | $101,521,849 | $169,717,635 |
| interest expense | $0 | $0 | $0 | $0 | $0 |
| depreciation and amortization expense | $91,744,118 | $87,327,032 | $81,884,594 | $73,430,152 | $67,825,011 |
| lease cost | $3,302,836 | $7,458,037 | $5,313,189 | $4,291,107 | $4,407,093 |
| Operating Margin | 2.5% | 2.0% | 11.2% | 1.7% | 8.0% |
| Definition: (tot oper rev - tot oper exp) / tot oper rev * 100 | |||||
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| total operating expense | $2,909,471,042 | $2,538,763,073 | $2,201,548,096 | $2,012,235,556 | $1,886,735,443 |
| Excess Margin | 2.7% | 3.1% | 12.9% | 4.8% | 8.3% |
| Definition: (tot oper rev - tot oper exp + non-oper rev) / (tot oper rev + non-oper rev) * 100 | |||||
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| total operating expense | $2,909,471,042 | $2,538,763,073 | $2,201,548,096 | $2,012,235,556 | $1,886,735,443 |
| non-operating revenue (non-patient revenue) | $4,057,509 | $29,082,344 | $47,140,642 | $67,224,437 | $6,678,416 |
| Personnel Expense as a percent of Total Operating Revenue | 29.3% | 30.5% | 24.8% | 28.8% | 27.7% |
| Definition: (salary expense + contract labor + fringe benefits ) / total operating rev * 100 | |||||
| salary expense | $812,165,153 | $700,673,572 | $615,268,584 | $565,539,241 | $533,169,309 |
| contract labor | $61,197,038 | $90,376,571 | $0 | $24,669,362 | $34,270,415 |
| fringe benefits | $135,789 | $55,110 | $33,313 | $12,295 | $1,549 |
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| Return on Equity | 2.1% | 2.3% | 10.1% | 3.6% | 6.4% |
| Definition: net income / (total assets - total liabilities) * 100 | |||||
| net income (before taxes) | $79,825,219 | $80,098,761 | $325,067,409 | $101,521,849 | $169,717,635 |
| total assets (general fund only) | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 | $3,191,582,342 | $2,775,349,603 |
| total liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| Return on Assets (ROA) | 2.1% | 2.2% | 9.4% | 3.2% | 6.1% |
| Definition: net income / total assets * 100 | |||||
| net income (before taxes) | $79,825,219 | $80,098,761 | $325,067,409 | $101,521,849 | $169,717,635 |
| total assets (general fund only) | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 | $3,191,582,342 | $2,775,349,603 |
| Current Ratio | -51.1 | 2.4 | 1.3 | 0.8 | 2.2 |
| Definition: total current assets / total current liabilities | |||||
| total current assets (general fund only) | $406,625,038 | $340,263,112 | $335,302,065 | $283,899,480 | $284,438,409 |
| total current liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| Quick Ratio | -42.8 | 1.9 | 1.1 | 0.7 | 1.7 |
| Definition: (total current assets - inventory) / total current liabilities | |||||
| total current assets (general fund only) | $406,625,038 | $340,263,112 | $335,302,065 | $283,899,480 | $284,438,409 |
| inventory (general fund only) | $66,021,642 | $68,934,055 | $69,170,691 | $59,958,395 | $56,299,747 |
| total current liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| Days Cash on Hand | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Definition: (cash on hand + market securities) / [(total operating expenses - depreciation ) / 365] | |||||
| cash on hand (general fund only) | $8,015 | $8,300 | $11,339 | $9,000 | $9,000 |
| market securities (temporary investments) (general fund only) | $0 | $0 | $0 | $0 | $0 |
| total operating expense | $2,909,471,042 | $2,538,763,073 | $2,201,548,096 | $2,012,235,556 | $1,886,735,443 |
| depreciation expense | $91,744,118 | $87,327,032 | $81,884,594 | $73,430,152 | $67,825,011 |
| Days Cash on Hand - All Sources | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Definition: (cash on hand + mkt securities + investments) / [(total operatingexp - depreciation exp) / 365] | |||||
| cash on hand (general fund only) | $8,015 | $8,300 | $11,339 | $9,000 | $9,000 |
| market securities (temporary investments) (general fund only) | $0 | $0 | $0 | $0 | $0 |
| investments (general fund only) | $0 | $0 | $0 | $0 | $2,545,313 |
| total operating expense | $2,909,471,042 | $2,538,763,073 | $2,201,548,096 | $2,012,235,556 | $1,886,735,443 |
| depreciation expense | $91,744,118 | $87,327,032 | $81,884,594 | $73,430,152 | $67,825,011 |
| Days in Net Patient Accounts Receivable | 41.1 | 37.7 | 38.4 | 39.6 | 40.1 |
| Definition: (accounts receivable - allowances for uncollectible) / (total operating revenue / 365) | |||||
| accounts receivable (general fund only) | $1,726,418,440 | $1,270,291,439 | $1,265,481,897 | $1,140,764,600 | $1,123,254,055 |
| allowances for uncollectible (general fund only) | $1,390,139,525 | $1,002,627,912 | $1,004,863,367 | $918,996,527 | $897,968,272 |
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| Days in Net Total Receivable | 41.2 | 37.8 | 38.7 | 39.7 | 40.2 |
| Definition: (accounts receivable + notes receivable + other receivables - allowances for uncollectible) / (total operating revenue / 365) | |||||
| accounts receivable (general fund only) | $1,726,418,440 | $1,270,291,439 | $1,265,481,897 | $1,140,764,600 | $1,123,254,055 |
| notes receivable (general fund only) | $0 | $0 | $0 | $0 | $0 |
| other receivables (general fund only) | $643,322 | $622,153 | $2,046,512 | $723,711 | $440,000 |
| allowances for uncollectible (general fund only) | $1,390,139,525 | $1,002,627,912 | $1,004,863,367 | $918,996,527 | $897,968,272 |
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| Average Payment Period (days) | -1.0 | 21.2 | 43.4 | 63.1 | 26.3 |
| Definition: total current liabilities / [(total operating expenses + total other expenses - depreciation) / 365] | |||||
| total current liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| total operating expense | $2,909,471,042 | $2,538,763,073 | $2,201,548,096 | $2,012,235,556 | $1,886,735,443 |
| total other expense | $0 | $0 | $0 | $0 | $0 |
| depreciation expense | $91,744,118 | $87,327,032 | $81,884,594 | $73,430,152 | $67,825,011 |
| Inventory Turnover | 45.3 | 38.0 | 36.5 | 35.3 | 36.5 |
| Definition: (total operating revenue + non-operating revenue) / inventory | |||||
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| non-operating revenue (non-patient revenue) | $4,057,509 | $29,082,344 | $47,140,642 | $67,224,437 | $6,678,416 |
| inventory (general fund only) | $66,021,642 | $68,934,055 | $69,170,691 | $59,958,395 | $56,299,747 |
| Total Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 |
| Definition: (total operating revenue + non-operating revenue) / total assets | |||||
| total operating revenue (net patient revenue) | $2,985,238,752 | $2,589,779,490 | $2,479,474,863 | $2,046,532,968 | $2,049,774,662 |
| non-operating revenue (non-patient revenue) | $4,057,509 | $29,082,344 | $47,140,642 | $67,224,437 | $6,678,416 |
| total assets (general fund only) | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 | $3,191,582,342 | $2,775,349,603 |
| Long Term Debt to Net Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Definition: total long term liabilities / (total assets - total liabilities) | |||||
| total long term liabilities (general fund only) | $0 | $0 | $0 | $0 | $0 |
| total assets (general fund only) | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 | $3,191,582,342 | $2,775,349,603 |
| total liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| Total Debt to Net Assets | 0.00 | 0.04 | 0.08 | 0.12 | 0.05 |
| Definition: total liabilities / (total assets - total liabilities) | |||||
| total assets (general fund only) | $3,833,020,545 | $3,596,067,018 | $3,465,829,011 | $3,191,582,342 | $2,775,349,603 |
| total liabilities (general fund only) | $-7,957,731 | $142,105,323 | $251,944,136 | $335,099,532 | $131,274,323 |
| Average Age of Plant | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Definition: accumulated depreciation / depreciation expense | |||||
| accumulated depreciation | $0 | $0 | $0 | $0 | $0 |
| depreciation expense | $91,744,118 | $87,327,032 | $81,884,594 | $73,430,152 | $67,825,011 |